Brevan Howard Capital Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$798K Buy
+27,696
New +$619K 0.01% 1189
2026
Q1
– Sell
-9,773
Closed -$251K – 2405
2025
Q4
$251K Buy
+9,773
New +$225K ﹤0.01% 1467
2025
Q3
– Sell
-43,893
Closed -$966K – 2200
2025
Q2
$966K Sell
43,893
-57,562
-57% -$1.26M 0.01% 1080
2025
Q1
$2.27M Buy
101,455
+49,040
+94% +$1.06M 0.02% 275
2024
Q4
$904K Buy
+52,415
New +$813K 0.01% 457
2024
Q3
– Sell
-7,405
Closed -$212K – 1360
2024
Q2
$212K Buy
+7,405
New +$223K ﹤0.01% 872
2024
Q1
– Sell
-7,853
Closed -$292K – 1276
2023
Q4
$292K Buy
+7,853
New +$264K ﹤0.01% 722

Other funds holding PGNY

Brevan Howard Capital Management's PGNY Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Progyny (PGNY) in Q2 2026: 27,696 shares worth $798K. The stake represents 0.01% of the portfolio and ranks #1189 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in PGNY as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in PGNY in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.27M in Q1 2025. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Brevan Howard Capital Management held 27,696 shares of Progyny worth $798K as of Q2 2026.
  • Progyny was a new Brevan Howard Capital Management position in Q2 2026.
  • Progyny made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1189 holding.
  • Brevan Howard Capital Management first reported a position in Progyny in Q4 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Progyny position peaked at $2.27M in Q1 2025.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.